Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2000; 35:1311-1316
© 2000 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hung, J.
Right arrow Articles by Lang, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hung, J.
Right arrow Articles by Lang, P.

Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement

Judy Hung, MD*, Michael J. Landzberg, MD{dagger} {ddagger}, Kathy J. Jenkins, MD, MPH{dagger}, Mary Etta E. King, MD, FACC*, James E. Lock, MD, FACC{dagger}, Igor F. Palacios, MD, FACC* and Peter Lang, MD, FACC{dagger}

* Cardiac Unit, Massachusetts General Hospital, Boston, Massachusetts, USA
{dagger} Department of Cardiology, Children’s Hospital, Boston, Massachusetts, USA
{ddagger} Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts, USA



View larger version (8K):

[in a new window]
 
Figure 1 Kaplan-Meier analysis of the recurrence rate of stroke or transient ischemic attack following transcatheter device closure.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement